FDA says shortage of GLP-1 tirzepatide is over
The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over.
Dec 19, 2024
0
0
Breast cancer risk increases with weight gain after age 35, finds study
The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology & Medicine.
Dec 18, 2024
0
0
Some racial and ethnic groups may face barriers to obtaining obesity medications
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites, new research suggests. The differences could not be fully ...
Dec 18, 2024
1
0
Infant breast milk supplement commonly used in Sweden may contribute to childhood obesity
Many infants in Sweden are given milk cereal drinks, ready-to-mix liquid drink complements to breast milk, after six months of age. New research in Acta Paediatrica found evidence that these products are linked to early rapid ...
Dec 18, 2024
0
0
Calorie content influences food choices regardless of obesity status, study shows
Higher calorie foods were preferred among individuals with and without obesity despite similar taste and texture, according to a study published December 17 in the open-access journal PLOS Biology by Albino Oliveira-Maia ...
Dec 17, 2024
0
5
Study finds brain enzyme inhibition reduces obesity in mice
Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated hospital research center ...
Dec 16, 2024
0
26
Weight-loss drugmaker Novo Nordisk invests $1.2 bn in new factory in Denmark
Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was investing 8.5 billion kroner ($1.2 billion) to build a new factory in Denmark to produce drugs ...
Dec 16, 2024
0
0
U.S. adult obesity rate fell in 2023, as use of GLP-1 meds rose
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds.
Dec 13, 2024
0
0
Gene expression differences in fat tissue may inform targeted treatment for obesity
New research reveals significant differences in gene expression related to metabolism, inflammation and cardioprotection in the fat tissue of lean and obese mice. These findings could advance the development of targeted therapies ...
Dec 12, 2024
0
0
Quality breakfast linked to reduced cardiovascular risk
Having a quality breakfast that provides the right amount of energy to face the day, around a quarter of daily intake, reduces the risk of cardiovascular disease.
Dec 11, 2024
0
2
Research uncovers key bariatric surgery complication cause
Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ordinary hypoglycemia, in which low blood sugar is usually associated with little food, postprandial ...
Dec 10, 2024
1
2
Study links metal levels in urine to childhood obesity risk
Researchers from the Granada Biosanitary Research Institute and the University of Granada have revealed positive and negative associations between exposure to a combination of different metals and overweight and obesity in ...
Dec 10, 2024
0
0
Are weight loss drugs like Ozempic, Wegovy safe for kids?
Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more."
Dec 9, 2024
0
0
Who gets obesity drugs covered by insurance? In North Carolina, it helps if you're on Medicaid
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don't work.
Dec 9, 2024
0
0
Weight loss brings Americans big health care savings
The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers.
Dec 5, 2024
0
0
Zepbound bests Wegovy for weight loss in new trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Dec 4, 2024
0
1
Paternal weight associated with baby's size at birth, study finds
A study in Brazil involving 89 father-mother-baby triads points to an association between paternal overweight and newborn birth weight: the higher the father's body mass index (BMI, weight divided by height squared), the ...
Dec 4, 2024
0
0
About one-third eligible for weight loss drugs meet trial exclusion criteria
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists ...
Dec 3, 2024
0
0
What makes oatmeal the ideal breakfast for heart health and weight loss?
Oatmeal is a nutritious, inexpensive and versatile way to incorporate whole grains into the diet. Oats made history when they became the first food with a Food and Drug Administration health claim label in 1997. This claim ...
Dec 3, 2024
0
3
Obesity treatment in a natural, food-grade microcapsule has no unpleasant side effects
As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with significant side effects, accessibility and cost issues, alternatives are needed.
Dec 2, 2024
0
0
Philly's soda tax had an impact on health in the city, research finds
When University of Pennsylvania researcher Christina Roberto set out to study Philadelphia's soda tax, she wasn't convinced she would find much health impact.
Nov 29, 2024
0
13
Why some people don't lose weight with Wegovy
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don't work for everyone.
Nov 29, 2024
0
0
Team discovers that a key mechanism in fat cells protects the body against energetic excess
A research team has identified an essential mechanism in fat cells (adipocytes) that enables them to enlarge safely to store energy. This process avoids tissue damage and protects the body from the toxic effects of accumulating ...
Nov 28, 2024
0
8